CD30 expression in diffuse large B-cell lymphoma and primary mediastinal lymphoma: frequency, association with prognostic factors, and impact on survival

Marcelo Bellesso, Ibere Cauduro Soares, Frederico Rafael Moreira, Juliana Pereira, Vanderson Rocha

Open source

DOI
10.1016/j.htct.2026.106493
Published
2026-10
Container
Hematology, Transfusion and Cell Therapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.htct.2026.106493,
  title = {CD30 expression in diffuse large B-cell lymphoma and primary mediastinal lymphoma: frequency, association with prognostic factors, and impact on survival},
  author = {Marcelo Bellesso and Ibere Cauduro Soares and Frederico Rafael Moreira and Juliana Pereira and Vanderson Rocha},
  year = {2026},
  journal = {Hematology, Transfusion and Cell Therapy},
  doi = {10.1016/j.htct.2026.106493},
  url = {https://doi.org/10.1016/j.htct.2026.106493}
}

RIS

TY  - JOUR
TI  - CD30 expression in diffuse large B-cell lymphoma and primary mediastinal lymphoma: frequency, association with prognostic factors, and impact on survival
AU  - Marcelo Bellesso
AU  - Ibere Cauduro Soares
AU  - Frederico Rafael Moreira
AU  - Juliana Pereira
AU  - Vanderson Rocha
PY  - 2026
JO  - Hematology, Transfusion and Cell Therapy
DO  - 10.1016/j.htct.2026.106493
UR  - https://doi.org/10.1016/j.htct.2026.106493
ER  - 

APA

Bellesso, M., Soares, I. C., Moreira, F. R., Pereira, J., & Rocha, V. (2026). CD30 expression in diffuse large B-cell lymphoma and primary mediastinal lymphoma: frequency, association with prognostic factors, and impact on survival. Hematology, Transfusion and Cell Therapy. https://doi.org/10.1016/j.htct.2026.106493

Source records